A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

NCT07160725 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study of BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies

NCT00351325 ·Status: TERMINATED ·Phase: PHASE1

BI 2536 BS in Patients With Advanced Solid Tumours and Repeated Administration in Patients With Clinical Benefit

NCT02211872 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors

NCT02298387 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

NCT06476808 ·Status: RECRUITING ·Phase: PHASE1

Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies

NCT02030067 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment

NCT00005611 ·Status: UNKNOWN ·Phase: PHASE1

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors

NCT00569036 ·Status: COMPLETED ·Phase: PHASE1

A Study Of PF-06647263 In Patients With Advanced Solid Tumors

NCT02078752 ·Status: TERMINATED ·Phase: PHASE1

BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

NCT00004927 ·Status: COMPLETED ·Phase: PHASE1

Multiple Ascending Dose Study of BMS-777607 in Subjects With Advanced or Metastatic Solid Tumors

NCT00605618 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

BMS-214662 in Treating Patients With Advanced Solid Tumors

NCT00004877 ·Status: COMPLETED ·Phase: PHASE1

A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours

NCT02952248 ·Status: COMPLETED ·Phase: PHASE1

Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors

NCT03780517 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of AMG 228 to Treat Solid Tumors

NCT02437916 ·Status: TERMINATED ·Phase: PHASE1

Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan

NCT01018745 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma

NCT01723020 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

NCT04272034 ·Status: TERMINATED ·Phase: PHASE1

A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors

NCT00886782 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors

NCT01508104 ·Status: TERMINATED ·Phase: PHASE1

A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer

NCT00670189 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of PM02734 in Subjects With Advanced Malignant Solid Tumors

NCT00404521 ·Status: TERMINATED ·Phase: PHASE1

Clinical Trial of Continuing Treatment for Patients Who Have Participated on a Prior Protocol Investigating Tanespimycin

NCT00779428 ·Status: COMPLETED ·Phase: PHASE2

A Trial Of SU14813 In Patients With Advanced Solid Malignancies

NCT00982267 ·Status: COMPLETED ·Phase: PHASE1

Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumours

NCT02171702 ·Status: COMPLETED ·Phase: PHASE1